PLAT and COVID-19: In this context, the regulatory role of PAI-1 may further contribute to explain this effect since PAI-1, tPA, and the thrombin activatable fibrinolysis inhibitor (TAFI) augmented in parallel with COVID-19 severity [110, 119].